Effects of long non-coding RNA (lncRNA) cancer susceptibility candidate 2c (CASC2c) on proliferation, metastasis and drug resistance of non-small cell lung cancer (NSCLC) cells through ERK1/2 and β-catenin signaling pathways-Reference-Cited by-同舟云学术

Effects of long non-coding RNA (lncRNA) cancer susceptibility candidate 2c (CASC2c) on proliferation, metastasis and drug resistance of non-small cell lung cancer (NSCLC) cells through ERK1/2 and β-catenin signaling pathways

Published:2019-09 Issue:9 Volume:215 Page:152522
ISSN:0344-0338
Container-title:Pathology - Research and Practice
language:en
Short-container-title:Pathology - Research and Practice

Author:

Tong Lingfei,Wu Wenming

Publisher

Elsevier BV

Subject

Cell Biology,Pathology and Forensic Medicine

Reference48 articles.

1. Cancer statistics, 2018;Siegel;CA Cancer J. Clin.,2018

2. Management of stage IIIA non-small cell lung cancer by thoracic surgeons in North America;Veeramachaneni;Ann. Thorac. Surg.,2012

3. Effect analysis of chemoradiotherapy after operation in patients with stage III A non-small cell lung cancer;Chen;Asian Pac. J. Trop. Med.,2012

4. Long noncoding RNAs in cancer pathways;Schmitt;Cancer Cell,2016

5. Long noncoding RNAs: novel molecules in cardiovascular biology, disease and regeneration;Hou;Exp. Mol. Pathol.,2016

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High CASC expression predicts poor prognosis of lung cancer: A systematic review with meta-analysis;PLOS ONE;2024-04-04

2. The effect of endogenous bone marrow derived mesenchymal stem cells on the activity of β-catenin signaling pathway on chemotherapy resistance of osteosarcoma;Materials Express;2023-11-01

3. The Emerging Role of EMT-related lncRNAs in Therapy Resistance and their Applications as Biomarkers;Current Medicinal Chemistry;2022-08

4. DNAJC12 activated by HNF1A enhances aerobic glycolysis and drug resistance in non-small cell lung cancer;Annals of Translational Medicine;2022-04

5. LINC01140 inhibits nonsmall cell lung cancer progression and cisplatin resistance through the miR‐4742‐5p/TACC1 axis;Journal of Biochemical and Molecular Toxicology;2022-03-21